Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
10%+ Owner
-
Issuer Symbol
-
ACRV on Nasdaq
There are no Buy or Sell transactions made by Biomedical Innovation Master Investors (Cayman) I. L.P. Wellington since 11 Mar 2025
Holdings reported by Biomedical Innovation Master Investors (Cayman) I. L.P. Wellington for Acrivon Therapeutics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Common Stock |
888,130 |
$3,863,366 |
$4.35 |
17 Nov 2022 |
Direct |
|
|
| Series B Preferred Stock |
0 |
|
|
17 Nov 2022 |
Direct |
Common Stock |
|
Transactions reported by Biomedical Innovation Master Investors (Cayman) I. L.P. Wellington for Acrivon Therapeutics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.